Fully Open Meditron: An Auditable Pipeline for Clinical LLMs
Research paper by Xavier Theimer-Lienhard and collaborators. arXiv record dated 2026-05-29. Research area: Artificial intelligence.
Resource information
- Authors
- Xavier Theimer-Lienhard, Mushtaha El-Amin, Fay Elhassan, Sahaj Vaidya, Victor Cartier-Negadi, David Sasu, Lars Klein, Mary-Anne Hartley
- Research area
- Artificial intelligence
- Application domain
- Healthcare
- AI methods
- Large language models
- Research topics
- cs.AI, cs.CL
- arXiv record date
- 2026-05-29
- Publication
- arXiv
- Upstream last modified
- Jun 1, 2026
- License
- CC BY 4.0
- Last record update
- Nov 4, 2026
Abstract
Clinical decision support systems (CDSS) require scrutable, auditable pipelines that enable rigorous, reproducible validation. Yet current LLM-based CDSS remain largely opaque. Most "open" models are open-weight only, releasing parameters while withholding the data provenance, curation procedures, and generation pipelines that determine model behavior. Fully Open (FO) models, which expose the complete training stack end-to-end, do not currently exist in medicine. We introduce Fully Open Meditron, the first fully open pipeline for building LLM-CDSS, comprising a clinician-audited training corpus, a reproducible data construction and training framework, and a use-aligned evaluation protocol. The corpus unifies eight public medical QA datasets into a normalized conversational format and expands coverage with three clinician-vetted synthetic extensions: exam-style QA, guideline-grounded QA derived from 46,469 clinical practice guidelines, and clinical vignettes. The pipeline enforces system-wide decontamination, gold-label resampling of teacher generations, and end-to-end validation by a four-physician panel. We evaluate using an LLM-as-a-judge protocol over expert-written clinical vignettes, calibrated against 204 human raters. We apply the recipe to five FO base models (Apertus-70B/8B-Instruct, OLMo-2-32B-SFT, EuroLLM-22B/9B-Instruct). All MeditronFO variants are preferred over their bases. Apertus-70B-MeditronFO improves +6.6 points over its base (47.2% to 53.8%) on aggregate medical benchmarks, establishing a new FO SoTA. Gemma-3-27B-MeditronFO is preferred over MedGemma in 58.6% of LLM-as-a-judge comparisons and outperforms it on HealthBench (58% vs 55.9%). These results show that fully open pipelines can achieve state-of-the-art domain-specific performance without sacrificing auditability or reproducibility.